| THE UNIVERSITY OF WARWICK Patent applications |
| Patent application number | Title | Published |
|---|
| 20100291236 | OSMIUM COMPOUNDS - The present invention relates to osmium compounds of formula (I), their preparation and use in methods of treatment, particularly for cancer treatment. | 11-18-2010 |
| 20100011309 | DATA VISUALISATION SYSTEMS - A method in a computer of building a visual representation model for presenting plural forms of data from a data source to a user, comprising the steps of creating a first file of data (model file) representative of one or more physical attributes of one or more elements associated with one of a plurality of nodes in the visual representation, creating a second file of data (configuration file) representative of visual attributes of the one or more elements for each of the plurality of nodes in the visual representation and associating a variation in the visual appearance of the nodes in correlation with variation in the data from the data source which is associated with the nodes. | 01-14-2010 |
| 20090279773 | IMAGING APPARATUS AND METHOD - Apparatus for inspecting an article comprising: a controller configured to generate a drive signal having a periodic amplitude variation; a source, the source being operable by the controller to emit a source beam thereby to irradiate an article, the source beam comprising a beam of electromagnetic radiation having a periodic amplitude variation corresponding to that of the drive signal; and a detector, the detector being configured to detect a portion of the source beam that has been transmitted through at least a portion of the article, and to generate a detector signal having an amplitude variation corresponding to the amplitude variation of said portion of the source beam, the controller being further configured to generate a difference value corresponding to a difference between the amplitude of the detector signal and the amplitude of a reference signal. | 11-12-2009 |
| 20090191158 | DEFECTIVE INTERFERING VIRUS - Cloned, i.e. defined, defective interfering (DI) influenza A virus is produced in embryonated hens eggs using a method which generates large quantities of DI virus material. Cloned DI virus is then used in tests on mice and ferrets given a lethal challenge of wild-type influenza A virus. When cloned DI influenza A virus is co-administered with a lethal dose of virulent influenza A virus, mice are protected compared to a control of inactivated cloned DI influenza A virus. Mice which survived the administration of cloned DI influenza A virus and infective challenge virus are three weeks later still protected against lethal challenge with infective virus. Control mice which received only cloned DI influenza A virus and no lethal challenge are not protected three weeks later on lethal challenge with infective virus. | 07-30-2009 |
| 20090155334 | IMPLANT FOR TISSUE ENGINEERING - The invention provides a process for the production of a monolithic implant for use in tissue engineering, the process comprising the steps of plasticising at least one biocompatible material into a paste, extruding the paste through a die, and drying the extruded material to eliminate an aqueous and/or non-aqueous component. The invention also relates to a monolithic implant as thereby manufactured, and the use of such an implant as a scaffold for tissue-engineering and as a transplant tissue in reconstructive or replacement surgery. | 06-18-2009 |
